Epstein Secrets

le Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Latin America — Tom Lantos Hu

ehnam; Fermat Capital Management Senior Underwriter and Director of New Markets Joanna Syroka; Environmental Defense Fund Director of Working Lands Maggie Monast; and ClearPath Executive Director Rich Powell; 1:00 PM Cabinet Officers: * Treasury Secretary Mnuchin participates in Independent Community Bankers

le Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Latin America - Tom Lantos Hu

ehnam; Fermat Capital Management Senior Underwriter and Director of New Markets Joanna Syroka; Environmental Defense Fund Director of Working Lands Maggie Monast; and ClearPath Executive Director Rich Powell; 1:00 PM Cabinet Officers: EFTA00148937 • Treasury Secretary Mnuchin participates in Independent C

e Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Latin America - Tom Lantos Hu

apital Management Senior Underwriter and Director EFTA01658536 of New Markets Joanna Syroka; Environmental Defense Fund Director of Working Lands Maggie Monast; and ClearPath Executive Director Rich Powell; 1:00 PM Cabinet Officers: • Treasury Secretary Mnuchin participates in Independent Community Banker